U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said at the inauguration of the site on Monday.

NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in southern India, with additional investments anticipated, CEO Robert Bradway announced during the site’s inauguration on February 24.

US biotech major Amgen will invest about $200 million this year in its new technology center in southern India.

Amgen, a leading American biopharmaceutical company, is set to invest $200 million in a new Technology and Innovation Centre. The inauguration took place with notable attendees, including India's Chief Minister Revanth Reddy.

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further advance its pipeline of medicines, while creating significant opportunities for local talent.

US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway announcing a $2.

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI and data-driven drug development. CEO Robert Bradway, speaking at the sites inauguration,

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert Bradway said at the inauguration of the site on Monday.

Amgen (NASDAQ:AMGN) reportedly plans to invest over $200M in its newly opened technology and innovation center in Hyderabad, India. The site, which was officially opened on Monday, is expected to employ around 2,